Publication 6/01/2009

Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.

Pichla-Gollon SL, Lin SW, Hensley SE, Lasaro MO, Herkenhoff-Haut L, Drinker M, Tatsis N, Gao GP, Wilson JM, Ertl HC, Bergelson JM

Journal Of Virology

Publication 3/01/2008

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.

Reyes-Sandoval A, Sridhar S, Berthoud T, Moore AC, Harty JT, Gilbert SC, Gao G, Ertl HC, Wilson JC, Hill AV

European Journal Of Immunology

Publication 3/01/2007

A CD46-binding chimpanzee adenovirus vector as a vaccine carrier.

Tatsis N, Blejer A, Lasaro MO, Hensley SE, Cun A, Tesema L, Li Y, Gao GP, Xiang ZQ, Zhou D, Wilson JM, Ertl HC

Molecular Therapy : The Journal Of The American Society Of Gene Therapy

Publication 2/01/2007

Structure-based identification of a major neutralizing site in an adenovirus hexon.

Pichla-Gollon SL, Drinker M, Zhou X, Xue F, Rux JJ, Gao GP, Wilson JM, Ertl HC, Burnett RM, Bergelson JM

Journal Of Virology

Publication 3/01/2006

Chimpanzee-origin adenovirus vectors as vaccine carriers.

Tatsis N, Tesema L, Robinson ER, Giles-Davis W, McCoy K, Gao GP, Wilson JM, Ertl HC

Gene Therapy

Publication 7/01/2004

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes.

Reyes-Sandoval A, Fitzgerald JC, Grant R, Roy S, Xiang ZQ, Li Y, Gao GP, Wilson JM, Ertl HC

Journal Of Virology